Production and characterization of monoclonal antibodies against the extracellular domain of CA 125

Immunological Investigations

Volumn 39, Issue 2, 2010, Pages 114-131

  Shojaeian, Sorour ^a   Allameh, Abdolamir ^a   Zarnani, Amir Hassan ^b,c   Chamankhah, Mahmood ^b   Ghods, Roya ^b   Bayat, Ali Ahmad ^b   Jeddi Tehrani, Mahmood ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carcinoma antigen 125; Immunofluorescence; Immunohistochemistry; Monoclonal antibody; Ovarian cancer; Western blot

Indexed keywords

CA 125 ANTIGEN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL LYSATE; CELL MIGRATION; CLONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; HYBRIDOMA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CA-125 ANTIGEN; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN ISOTYPES; IMMUNOPRECIPITATION; MICE; MICE, INBRED STRAINS; OVARIAN NEOPLASMS;

EID: 76649122822     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820130903496785     Document Type: Article

References (30)

1. Bast, R. C. Jr., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., Knapp, R. C. (1981). Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 68:1331-1337.
2. Bast, R. C. Jr., Klug, T. L., St. John, E., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., Zurawski, V. R. Jr., Knapp, R. C. (1983). A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309:883-887.
3. Bon, G. G., Kenemans, P., Verstraeten, R., van Kamp, G. J., Hilgers, J. (1996). Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values. Am. J. Obstet. Gynecol. 174:107-114.
4. Cannon, M. J., Santin, A. D., O'Brien, T. J. (2004). Immunological treatment of ovarian cancer. Curr. Opin. Obstet. Gynecol. 16:87-92.
5. Davis, H. M., Zurawski, V. R. Jr., Bast, R. C. Jr., Klug, T. L. (1986). Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res. 46:6143-6148.
6. de los Frailes, M. T., Stark, S., Jaeger, W., Hoerauf, A., Wildt, L. (1993). Purification and characterization of the CA 125 tumor-associated antigen from human ascites. Tumour Biol. 14:18-29.
7. Dorigo, O., Berek, J. S. (2007). CA125. Megadaltons of novel opportunities. Gynecol. Oncol. 104:505-507.
8. Høgdall, E. (2008). Cancer antigen 125 and prognosis. Curr. Opin. Obstet. Gynecol. 20:4-8.
9. Hu, S. L., Klaniecki, J., Dykers, T., Sridhar, P., Travis, B. M. (1991). Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160. AIDS Res. Hum. Retroviruses 7:615-620.
10. Jeddi-Tehrani, M., Abbasi, N., Dokouhaki, P., Ghasemi, J., Rezania, S., Ostadkarampour, M., Rabbani, H., Akhondi, M. A., Fard, Z. T., Zarnani, A. H. (2009). Indoleamine 2,3-dioxygenase is expressed in the endometrium of cycling mice throughout the oestrous cycle. J. Reprod. Immunol. 80:41-48.
11. Kobayashi, H., Ida, W., Terao, T., Kawashima, Y. (1993). Molecular characteristics of the CA 125 antigen produced by human endometrial epithelial cells: comparison between eutopic and heterotopic epithelial cells. Am. J. Obstet. Gynecol. 169:725-730. (Pubitemid 23290200)
12. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
13. Lloyd, K. O., Yin, B. W. (2001). Synthesis and secretion of the ovarian cancer antigen CA 125 by the human cancer cell line NIH:OVCAR-3. Tumour Biol. 22:77-82.
14. Lloyd, K. O., Yin, B. W., Kudryashov, V. (1997). Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule. Int. J. Cancer 71:842-850.
15. Matsuoka, Y., Nakashima, T., Endo, K., Yoshida, T., Kunimatsu, M., Sakahara, H., Koizumi, M., Nakagawa, T., Yamaguchi, N., Torizuka, K. (1987). Recognition of ovarian cancer antigen CA 125 by murine monoclonal antibody produced by immunization of lung cancer cells. Cancer Res. 47:6335-6340.
16. Nagata, A., Hirota, N., Sakai, T., Fujimoto, M., Komoda, T. (1991). Molecular nature and possible presence of a membranous glycan- phosphatidylinositol anchor of CA 125 antigen. Tumour Biol. 12:279-286.
17. Nap, M., Vitali, A., Nustad, K., Bast, R. C. Jr., O'Brien, T. J., Nilsson, O., Seguin, P., Suresh, M. R., Børmer, O. P., Saga, T., de Bruijn, H. W., Nozawa, S., Kreutz, F. T., Jette, D., Sakahara, H., Gadnell, M., Endo, K., Barlow, E. H., Warren, D., Paus, E., Hammarström, S., Kenemans, P., Hilgers, J. (1996). Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop. Tumour Biol. 17:325-331. (Pubitemid 26356807)
18. Nustad, K., Bast, R. C. Jr., Brien, T. J., Nilsson, O., Seguin, P., Suresh, M. R., Saga, T., Nozawa, S., Børmer, O. P., de Bruijn, H. W., Nap, M., Vitali, A., Gadnell, M., Clark, J., Shigemasa, K., Karlsson, B., Kreutz, F. T., Jette, D., Sakahara, H., Endo, K., Paus, E., Warren, D., Hammarström, S., Kenemans, P., Hilgers, J. (1996). Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine. Tumour Biol. 17:196-219. (Pubitemid 26227618)
19. Nustad, K., Lebedin, Y., Lloyd, K. O., Shigemasa, K., de Bruijn, H.W., Jansson, B., Nilsson, O., Olsen, K. H., O'Brien, T. J. (2002). Epitopes on CA 125 from cervical mucus and ascites fluid and characterization of six new antibodies. Third report from the ISOBM TD-1 workshop. Tumour Biol. 23:303-314
20. O'Brien, T. J., Beard, J. B., Underwood, L. J., Dennis, R. A., Santin, A. D., York, L. (2001). The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumour Biol. 22:348-366.
21. O'Brien, T. J., Tanimoto, H., Konishi, I., Gee, M. (1998). More than 15 years of CA 125: what is known about the antigen, its structure and its function. Int. J. Biol. Markers 13:188-195.
22. Patankar, M. S., Jing, Y., Morrison, J. C., Belisle, J. A., Lattanzio, F. A., Deng, Y., Wong, N. K., Morris, H. R., Dell, A., Clark, G. F. (2005). Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125. Gynecol. Oncol. 99:704-713
23. Reynolds, E. A., Moller, K. A. (2006). A review and an update on the screening of epithelial ovarian cancer. Curr. Probl. Cancer 30:203-232.
24. Rye, P. D., Nustad, K., Stigbrand, T. (2003). Tumor marker workshops. Tumour Biol. 24:165-171
25. Singleton, J., Guillen, D. E., Scully, M. S., Xue, J., Moffet, J., Chen, C., Patel, S. R., Schilling, A., Corisdeo, S., Yang, Q., Wang, B., Soltis, D. A., Albone, E. F. (2006). Characterization of antibodies to CA 125 that bind preferentially to the cellassociated form of the antigen. Tumour Biol. 27:122-132.
26. Stähli, C., Staehelin, T., Miggiano, V., Schmidt, J., Haring, P. (1980). High frequencies of antigen-specific hybridomas. dependence on immunization parameters and prediction by spleen cell analysis. J. Immunol. Meth. 32:297-304.
27. Towbin, H., Staehelin, T., Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U S A 76:4350-4354
28. Wang, H. Z., Wang, H. Y., Liang, R. Q., Ruan, K. C. (2004). Detection of tumor marker CA125 in ovarian carcinoma using quantum dots. Acta Biochim. Biophys. Sin. (Shanghai) 36:681-686.
29. Wang, W. W., Das, D., McQuarrie, S. A., Suresh, M. R. (2007). Design of a bifunctional fusion protein for ovarian cancer drug delivery: single-chain anti-CA 125 corestreptavidin fusion protein. Eur. J. Pharm. Biopharm. 65:398-405.
30. Yin, B. W., Dnistrian, A., Lloyd, K. O. (2002). Ovarian cancer antigen CA 125 is encoded by the MUC16 mucin gene. Int. J. Cancer 98:737-740.